⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 9, 2024JACC AdvancesOpen Access

Impact of Gender-Affirming Hormonal Therapy on Cardiovascular Risk Factors in Transgender Health

Saad Ur Rahman Nouraldeen Manasrah Nomesh Kumar Mohammad Hamza Aakanksha Sharma Neel Patel Bansari Patel Masooma Naseem Saman Razzaq Seemab Imtiaz Gill Hamza Naveed Khaled M. Harmouch Yasemin Bahar Muhammad Aamir Yasar Sattar M. Chadi Alraies

View Full Paper

Ask AI

Bookmark

Share

Abstract

Gender-affirming hormone therapy (GAHT) is common among transgender individuals, but its impact on lipid profile and cardiovascular health is not well studied.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rahman et al. (2024) studied this question.

synapsesocial.com/papers/68e58feab6db64358752b487 https://doi.org/10.1016/j.jacadv.2024.101265

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Gender-affirming hormone therapy and cardiovascular health in transgender adults2024 · 3 citations
2Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans2024 · 24 citations
3Gender-Affirming Hormone Therapy and Vascular Health: Walking the Line Between Caution and ConfidenceOriginal Research · 2026 · 2 citations
4Cardiac Mechanics in Altered Hormonal States as a Surrogate for Understanding the Effects of Transgender Hormone Therapyreview · 2022 · 1 citations
5Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A ReviewReview · 2022 · 41 citations